mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.004 |